药品名称NASACORT ALLERGY 24 HOUR
申请号020468产品号002
活性成分TRIAMCINOLONE ACETONIDE市场状态非处方药
剂型或给药途径SPRAY, METERED;NASAL规格0.055MG/SPRAY
治疗等效代码参比药物
批准日期2013/10/11申请机构SANOFI AVENTIS US LLC
化学类型New dosage form审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
59765732016/07/03YPDF格式
61433292016/07/03YPDF格式
79770452016/07/03YPDF格式
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020468042APLabel2016/10/11下载
020468042APLetter2016/10/12下载
020468040APLetter2015/06/22下载
020468040APLabel2015/06/22下载
020468039APLabel2014/09/23下载
020468039APLetter2014/09/23下载
020468035APLetter2013/10/11下载
020468035APLabel2013/10/15下载
020468034APLetter2013/07/03下载
020468034APLabel2013/07/03下载
020468033APLetter2013/07/03下载
020468033APLabel2013/07/03下载
020468024APLetter2008/09/23下载
020468024APLabel2008/09/25下载
020468013APLetter2004/03/10下载
020468013APLabel2004/04/05下载
020468012APLetter2004/01/09下载
020468012APLabel2004/01/15下载
020468011APLetter2003/12/22下载
020468011APLabel2003/12/29下载
020468001APReview2008/08/11下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020468042AP2016/09/22Labeling Revision
020468041AP2016/03/22Manufacturing Change or Addition
020468040AP2015/06/18Labeling Revision
020468039AP2014/09/19Labeling Revision
020468038AP2014/06/12Manufacturing Change or Addition
020468037AP2013/12/07Manufacturing Change or Addition
020468036AP2013/05/24Manufacturing Change or Addition
020468035AP2013/10/11OTC Labeling
020468034AP2013/07/02Efficacy Supplement with Clinical Data to Support
020468033AP2013/07/02Efficacy Supplement with Clinical Data to Support
020468024AP2008/09/19Patient Population Altered
020468020AP2013/12/07Manufacturing Change or Addition
020468013AP2004/03/08Labeling Revision
020468012AP2003/12/23Labeling Revision
020468011AP2003/12/17Labeling Revision
020468008AP2002/05/06Package Change
020468007AP2002/03/12Manufacturing Change or Addition
020468005AP2000/08/17Control Supplement
020468003AP1996/10/15Control Supplement
020468002AP1997/09/26New or Modified Indication
020468001AP1996/08/23Control Supplement
020468000AP1996/05/20Approval